Who
Sean D. Keohane
President and CEO
Company insider
Files Form 4 as: President and CEO, Cabot; Director, Chemours.
In numbers
- Trades disclosed
- 243
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $64.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 28 May 2008
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code A | $27K346.259 at $76.91 | filing |
| 11 Sep 2026filed 14 Sep 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code A | $23K283.636 at $79.68 | filing |
| 11 Sep 2026filed 14 Sep 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code A | $23K283.64 at $79.68 | filing |
| 28 Aug 2026filed 31 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Code M | $6.7M134,895 at $50.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Sold | $11.5M134,895 at $85.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code M | —134,895 at $0.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code M | —134,895 at $0.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Code M | $6.7M134,895 at $50.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Sold | $11.5M134,895 at $85.00 | filing |
| 24 Aug 2026filed 26 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Code M | $139K2,779 at $50.00 | filing |
| 24 Aug 2026filed 26 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Sold | $238K2,779 at $85.50 | filing |
| 24 Aug 2026filed 26 Aug 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code M | —2,779 at $0.00 | filing |
| 24 Aug 2026filed 26 Aug 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code M | —2,779 at $0.00 | filing |
| 24 Aug 2026filed 26 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Code M | $139K2,779 at $50.00 | filing |
| 24 Aug 2026filed 26 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Sold | $238K2,779 at $85.50 | filing |
| 7 Aug 2026filed 11 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Code M | $5.7M91,923 at $62.24 | filing |
| 7 Aug 2026filed 11 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Sold | $7.9M91,923 at $86.41 | filing |
| 7 Aug 2026filed 11 Aug 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code M | —91,923 at $0.00 | filing |
| 7 Aug 2026filed 11 Aug 2026 | CBT Cabotoption or derivative · Chemicals | SEC FORM 4 Code M | —91,923 at $0.00 | filing |
| 7 Aug 2026filed 11 Aug 2026 | CBT CabotChemicals | SEC FORM 4 Code M | $5.7M91,923 at $62.24 | filing |
News
Solstice Advanced Mat (NASDAQ:SOLS) vs. Cabot (NYSE:CBT) Head-To-Head AnalysisCBT · dailypolitical.com · 19 Oct 2026
0 headlines in the last 90 days name Sean D. Keohane; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.